Key facts
- It has raised $1.2M; the latest was Seed Round ($1.2M) in Nov 2025.
- Notable investors include Healthy.Capital, Rising Stars Ventures, Utrechtinc.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Guideways
- ·The full record, as it builds
Funding rounds
No funding rounds for Guideways are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guideways
Developer of a generative medtech approval AI agent platform designed to automate key approval and maintenance processes to unlock innovation and accelerate time to market. The company offers an integrated platform powered by agentic AI, tailor-made for medtech regulatory, quality and reimbursement processes, enabling customers to accelerate their product portfolio with faster time to market, lower maintenance costs and the ability to focus on strategic, value-add activities.
- Sector
- Information Technology
- HQ
- Utrecht, Netherlands
- Founded
- 2024
- Website
- guideways.ai/
- Ownership
- Privately Held (backing)
Guideways doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guideways shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guideways in its N-PORT filings yet. We sweep new filings monthly.